AbCellera Biologics (ABCL) Long-Term Debt Repayments (2020 - 2021)
AbCellera Biologics (ABCL) posted Long-Term Debt Repayments of $107000.0 for Q2 2021, down 93.76% on a QoQ basis from $1.7 million in Q1 2021, and up 272.58% year-over-year from $28718.6 in Q2 2020.
AbCellera Biologics (ABCL) Long-Term Debt Repayments (2020 - 2021) Analysis & Trends
AbCellera Biologics' Long-Term Debt Repayments history runs 2 years deep, the most recent figure standing at $107000.0 for Q2 2021.
- Quarterly Long-Term Debt Repayments rose 272.58% year-over-year to $107000.0 in Q2 2021, while the trailing twelve-month figure through Dec 2021 was $1.8 million (down 90.86% YoY) and the FY2021 annual result came in at $1.8 million, down 90.86% from the prior year.
- Long-Term Debt Repayments was $107000.0 for Q2 2021 at AbCellera Biologics, down from $1.7 million in the prior quarter.
- Across five years, Long-Term Debt Repayments topped out at $15.0 million in Q3 2020 and bottomed at -$62000.0 in Q2 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Repayments (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.64 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | AbCellera Biologics | 1.72 Bn | 1.72 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 107,000.00 |
| Jun 30, 2021 | 107,000.00 |
| Mar 31, 2021 | 1.72 Mn |
| Mar 31, 2021 | 1.72 Mn |
| Dec 31, 2020 | 2.97 Mn |
| Dec 31, 2020 | 2.97 Mn |
| Sep 30, 2020 | 15.00 Mn |
| Sep 30, 2020 | 15.00 Mn |
| Jun 30, 2020 | -62,000.00 |
| Jun 30, 2020 | -62,000.00 |
| Mar 31, 2020 | 2.03 Mn |
| Mar 31, 2020 | 2.03 Mn |